Kamada Ltd. (KMDA) Social Stream
Kamada Ltd (KMDA) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering KMDA.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-08-12 | 1 | $11 | $10 | $10.5 | $5.52 | 90.22% |
2021-11-23 | 2 | $11 | $10 | $10.5 | $5.52 | 90.22% |
2022-03-16 | 1 | $11 | $11 | $11 | $5.52 | 99.28% |
Price Target Last Issued March 16, 2022
The Trend in the Analyst Price Target
KMDA's average price target has moved down $0 over the prior 13 months.
KMDA reports an average of 89.51% for its upside potential over the past 50 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-05-15 | 0 | 11 | 11 | 11.0 | 5.73 | 91.97% |
2021-07-10 | 0 | 11 | 11 | 11.0 | 5.65 | 94.69% |
2021-08-01 | 2 | 11 | 11 | 11.0 | 5.44 | 102.21% |
2021-08-12 | 2 | 11 | 10 | 10.5 | 5.38 | 95.17% |
2021-08-14 | 1 | 11 | 11 | 11.0 | 5.47 | 101.1% |
KMDA Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
1 | 1 | 0 | 0 | 0 | 0 | 1 |
The Trend in the Broker Recommendations
KMDA's average broker recommendation rating improved by 0.5 over the prior 30 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KMDA as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, Kamada Ltd's number of analysts covering the stock is greater than 4.69% of them.
- Kamada Ltd's variance in analysts' estimates is lower than 83.52% of Pharmaceutical Products stocks.
- In terms of how Kamada Ltd fares relative to Healthcare stocks, note that its average analyst price target is higher than 51.12% of that group.
- Kamada Ltd's upside potential (average analyst target price relative to current price) is greater than 95.02% of Pharmaceutical Products stocks.
Stocks similar to Kamada Ltd in the Pharmaceutical Products industry regarding analyst recommendations and price targets are KALV, KALA, and JANX.
What is the outlook for KMDA? Use POWR Ratings for clearer insight into price direction.